July 31 (Reuters) - Cannabis company Cresco Labs said on Monday it has terminated the $2 billion deal to buy rival Columbia Care Inc. (Reporting by Arshreet Singh in Bengaluru; Editing by Krishna Chandra Eluri)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 CAD | -.--% | -0.76% | +46.37% |
May. 16 | Cresco Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Transcript : Cresco Labs Inc., Q1 2024 Earnings Call, May 15, 2024 |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,474 JPY | +1.64% | +4.52% | 319M | ||
2.62 CAD | -.--% | -0.76% | 666M | ||
0.325 CAD | -4.41% | -7.14% | 111M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.37% | 666M | |
+40.73% | 739B | |
+31.11% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.83% | 240B | |
+9.51% | 210B | |
-5.15% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- CL Stock
- News Cresco Labs Inc.
- Cresco Labs terminates $2 bln deal to buy Columbia Care